EssilorLuxottica Société anonyme
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and instruments and equipment in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Ni… Read more
EssilorLuxottica Société anonyme (ESLOF) - Net Assets
Latest net assets as of December 2025: $39.48 Billion USD
Based on the latest financial reports, EssilorLuxottica Société anonyme (ESLOF) has net assets worth $39.48 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($63.87 Billion) and total liabilities ($24.39 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $39.48 Billion |
| % of Total Assets | 61.81% |
| Annual Growth Rate | 15.63% |
| 5-Year Change | 9.67% |
| 10-Year Change | 459.64% |
| Growth Volatility | 74.66 |
EssilorLuxottica Société anonyme - Net Assets Trend (2001–2025)
This chart illustrates how EssilorLuxottica Société anonyme's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EssilorLuxottica Société anonyme (2001–2025)
The table below shows the annual net assets of EssilorLuxottica Société anonyme from 2001 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $39.48 Billion | -3.72% |
| 2024-12-31 | $41.00 Billion | +5.43% |
| 2023-12-31 | $38.89 Billion | +1.95% |
| 2022-12-31 | $38.15 Billion | +5.97% |
| 2021-12-31 | $36.00 Billion | +9.75% |
| 2020-12-31 | $32.80 Billion | -7.17% |
| 2019-12-31 | $35.33 Billion | +6.23% |
| 2018-12-31 | $33.26 Billion | +380.16% |
| 2017-12-31 | $6.93 Billion | -1.80% |
| 2016-12-31 | $7.05 Billion | +15.79% |
| 2015-12-31 | $6.09 Billion | +15.82% |
| 2014-12-31 | $5.26 Billion | +30.17% |
| 2013-12-31 | $4.04 Billion | +3.07% |
| 2012-12-31 | $3.92 Billion | +13.39% |
| 2011-12-31 | $3.46 Billion | +13.59% |
| 2010-12-31 | $3.04 Billion | +11.19% |
| 2009-12-31 | $2.74 Billion | +15.72% |
| 2008-12-31 | $2.37 Billion | +9.12% |
| 2007-12-31 | $2.17 Billion | +13.77% |
| 2006-12-31 | $1.91 Billion | +12.91% |
| 2005-12-31 | $1.69 Billion | +25.98% |
| 2004-12-31 | $1.34 Billion | +10.76% |
| 2003-12-31 | $1.21 Billion | -0.38% |
| 2002-12-31 | $1.21 Billion | +0.40% |
| 2001-12-31 | $1.21 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to EssilorLuxottica Société anonyme's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1523.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $2.31 Billion | 5.96% |
| Common Stock | $82.97 Million | 0.21% |
| Other Components | $36.48 Billion | 93.83% |
| Total Equity | $38.87 Billion | 100.00% |
EssilorLuxottica Société anonyme Competitors by Market Cap
The table below lists competitors of EssilorLuxottica Société anonyme ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
3M Company
NYSE:MMM
|
$78.38 Billion |
|
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München
PINK:MURGF
|
$78.80 Billion |
|
Delta Electronics Inc
TW:2308
|
$79.20 Billion |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
$79.29 Billion |
|
Quanta Services Inc
NYSE:PWR
|
$78.15 Billion |
|
Bank of China Ltd H
PINK:BACHF
|
$77.92 Billion |
|
Ecolab Inc
NYSE:ECL
|
$77.81 Billion |
|
Sumitomo Mitsui Financial
PINK:SMFNF
|
$77.77 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EssilorLuxottica Société anonyme's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 40,376,000,000 to 38,874,435,000, a change of -1,501,565,000 (-3.7%).
- Net income of 2,314,132,942 contributed positively to equity growth.
- Dividend payments of 546,795,127 reduced retained earnings.
- Share repurchases of 375,859,173 reduced equity.
- New share issuances of 36,000,000 increased equity.
- Other factors decreased equity by 2,929,043,642.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.31 Billion | +5.95% |
| Dividends Paid | $546.80 Million | -1.41% |
| Share Repurchases | $375.86 Million | -0.97% |
| Share Issuances | $36.00 Million | +0.09% |
| Other Changes | $-2.93 Billion | -7.53% |
| Total Change | $- | -3.72% |
Book Value vs Market Value Analysis
This analysis compares EssilorLuxottica Société anonyme's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.17x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 43.89x to 3.17x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | $6.04 | $265.00 | x |
| 2002-12-31 | $6.01 | $265.00 | x |
| 2003-12-31 | $5.77 | $265.00 | x |
| 2004-12-31 | $6.17 | $265.00 | x |
| 2005-12-31 | $7.72 | $265.00 | x |
| 2006-12-31 | $8.71 | $265.00 | x |
| 2007-12-31 | $9.99 | $265.00 | x |
| 2008-12-31 | $10.94 | $265.00 | x |
| 2009-12-31 | $12.90 | $265.00 | x |
| 2010-12-31 | $14.11 | $265.00 | x |
| 2011-12-31 | $15.86 | $265.00 | x |
| 2012-12-31 | $17.36 | $265.00 | x |
| 2013-12-31 | $17.63 | $265.00 | x |
| 2014-12-31 | $22.88 | $265.00 | x |
| 2015-12-31 | $26.35 | $265.00 | x |
| 2016-12-31 | $30.51 | $265.00 | x |
| 2017-12-31 | $29.47 | $265.00 | x |
| 2018-12-31 | $123.28 | $265.00 | x |
| 2019-12-31 | $78.88 | $265.00 | x |
| 2020-12-31 | $73.50 | $265.00 | x |
| 2021-12-31 | $78.99 | $265.00 | x |
| 2022-12-31 | $84.04 | $265.00 | x |
| 2023-12-31 | $84.83 | $265.00 | x |
| 2024-12-31 | $87.77 | $265.00 | x |
| 2025-12-31 | $83.66 | $265.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EssilorLuxottica Société anonyme utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.95%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.13%
- • Asset Turnover: 0.45x
- • Equity Multiplier: 1.64x
- Recent ROE (5.95%) is below the historical average (12.11%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 13.61% | 7.92% | 0.96x | 1.78x | $43.53 Million |
| 2002 | 16.47% | 9.33% | 0.99x | 1.78x | $78.38 Million |
| 2003 | 18.79% | 10.68% | 0.85x | 2.07x | $105.76 Million |
| 2004 | 18.37% | 10.81% | 0.87x | 1.94x | $111.35 Million |
| 2005 | 17.20% | 11.88% | 0.80x | 1.81x | $120.53 Million |
| 2006 | 17.45% | 12.22% | 0.86x | 1.66x | $140.36 Million |
| 2007 | 17.10% | 12.61% | 0.83x | 1.64x | $152.33 Million |
| 2008 | 16.36% | 12.44% | 0.76x | 1.74x | $148.67 Million |
| 2009 | 14.38% | 11.95% | 0.78x | 1.53x | $119.07 Million |
| 2010 | 15.39% | 11.87% | 0.75x | 1.74x | $161.87 Million |
| 2011 | 15.21% | 12.07% | 0.68x | 1.85x | $173.13 Million |
| 2012 | 15.94% | 11.71% | 0.72x | 1.89x | $217.58 Million |
| 2013 | 15.79% | 11.71% | 0.67x | 2.02x | $217.40 Million |
| 2014 | 18.90% | 16.38% | 0.53x | 2.20x | $437.50 Million |
| 2015 | 13.26% | 11.27% | 0.56x | 2.10x | $186.30 Million |
| 2016 | 12.16% | 11.43% | 0.54x | 1.97x | $144.20 Million |
| 2017 | 12.13% | 10.53% | 0.61x | 1.89x | $138.60 Million |
| 2018 | 3.30% | 10.03% | 0.23x | 1.41x | $-2.20 Billion |
| 2019 | 3.10% | 6.19% | 0.33x | 1.51x | $-2.40 Billion |
| 2020 | 0.26% | 0.59% | 0.28x | 1.62x | $-3.14 Billion |
| 2021 | 4.12% | 7.31% | 0.33x | 1.69x | $-2.07 Billion |
| 2022 | 5.75% | 8.79% | 0.40x | 1.62x | $-1.59 Billion |
| 2023 | 5.99% | 9.01% | 0.42x | 1.58x | $-1.53 Billion |
| 2024 | 5.84% | 8.90% | 0.41x | 1.59x | $-1.68 Billion |
| 2025 | 5.95% | 8.13% | 0.45x | 1.64x | $-1.57 Billion |
Industry Comparison
This section compares EssilorLuxottica Société anonyme's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EssilorLuxottica Société anonyme (ESLOF) | $39.48 Billion | 13.61% | 0.62x | $78.22 Billion |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |